Conmed Corp (CNMD) Misses Q1 EPS by 1c; Updates Guidance
Get Alerts CNMD Hot Sheet
Price: $49.82 +0.69%
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Conmed Corp (NASDAQ: CNMD) reported Q1 EPS of $0.43, $0.01 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $194.3 million versus the consensus estimate of $192.9 million.
Conmed Corp sees Q2 2012 EPS of $0.42-$0.47, versus the consensus of $0.45. Conmed Corp sees Q2 2012 revenue of $190-$195 million, versus the consensus of $199 million.
Conmed Corp sees FY2012 EPS of $1.75-$1.85, versus prior guidance of $1.75-$1.88 and the consensus of $1.80. Conmed Corp sees FY2012 revenue of $775-$785 million, versus prior guidance of $780-$790 million and the consensus of $782.4 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.
Conmed Corp sees Q2 2012 EPS of $0.42-$0.47, versus the consensus of $0.45. Conmed Corp sees Q2 2012 revenue of $190-$195 million, versus the consensus of $199 million.
Conmed Corp sees FY2012 EPS of $1.75-$1.85, versus prior guidance of $1.75-$1.88 and the consensus of $1.80. Conmed Corp sees FY2012 revenue of $775-$785 million, versus prior guidance of $780-$790 million and the consensus of $782.4 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share